Skip to main content
Equibles

TD Asset Management Inc

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1056053 Toronto, A6
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$4,422,830
+$2,967,746 QoQ
Shares Held
118,670
+171.7% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 286 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,140,636,067 across 120 Biotechnology names. IDYA ranks #51 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 259,317 $161,694,522
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 207,960 $103,299,970
3 HALO
Halozyme Therapeutics, Inc.
 1,115,730 $87,328,187
4 ALNY
Alnylam Pharmaceuticals, Inc.
 233,696 $70,349,506
5 CYTK
Cytokinetics Inc
 385,130 $32,809,224
6 RPRX
Royalty Pharma plc
 567,497 $31,819,556
7 ASND
Ascendis Pharma A/S
 119,085 $31,762,351
8 KYMR
Kymera Therapeutics, Inc.
 272,900 $31,293,443

All Filings in IDYA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,422,830 118,670
2026-03-31 $1,455,084 43,670
2025-12-31 $1,591,602 46,040
2025-09-30 $719,432 26,440
2025-06-30 $736,456 35,036
2025-03-31 $573,889 35,036
2024-12-31 $1,677,953 65,290
2024-09-30 $2,600,611 82,090
2024-06-30 $4,096,985 116,690
2024-03-31 $7,981,333 181,890
2023-12-31 $4,899,010 137,690
2023-09-30 $3,066,438 113,656
2023-06-30 $872,508 37,128
2022-12-31 $263,501 14,502
2022-09-30 $216,369 14,502
2022-06-30 $200,127 14,502
2022-03-31 $390,553 34,902
2021-12-31 $1,780,139 75,302
2021-09-30 $1,697,684 66,602
2021-06-30 $1,213,263 57,802
2021-03-31 $890,767 37,905
2020-12-31 $329,000 23,500